139 related articles for article (PubMed ID: 23791740)
1. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.
Dai Y; Liu L; Zeng T; Zhu YH; Li J; Chen L; Li Y; Yuan YF; Ma S; Guan XY
Biochem Biophys Res Commun; 2013 Jul; 436(4):711-8. PubMed ID: 23791740
[TBL] [Abstract][Full Text] [Related]
2. Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways.
Chen H; Wu F; Xu H; Wei G; Ding M; Xu F; Deivasigamani A; Zhou G; Hui KM; Xia H
Cancer Gene Ther; 2022 Jul; 29(7):1033-1042. PubMed ID: 34857915
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression.
Yang X; Miao BS; Wei CY; Dong RZ; Gao PT; Zhang XY; Lu JC; Gao C; Wang XY; Sun HC; Zhou J; Fan J; Ke AW; Shi GM; Cai JB
Cancer Sci; 2019 Jul; 110(7):2133-2144. PubMed ID: 31066149
[TBL] [Abstract][Full Text] [Related]
5. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
[TBL] [Abstract][Full Text] [Related]
6. Proline-rich acidic protein 1 (PRAP1) is a novel interacting partner of MAD1 and has a suppressive role in mitotic checkpoint signalling in hepatocellular carcinoma.
Sze KM; Chu GK; Mak QH; Lee JM; Ng IO
J Pathol; 2014 May; 233(1):51-60. PubMed ID: 24374861
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH
Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716
[TBL] [Abstract][Full Text] [Related]
8. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
9. Loss of CENPF leads to developmental failure in mouse embryos.
Zhou CJ; Wang XY; Han Z; Wang DH; Ma YZ; Liang CG
Cell Cycle; 2019 Oct; 18(20):2784-2799. PubMed ID: 31478449
[TBL] [Abstract][Full Text] [Related]
10. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.
Kang YH; Ji NY; Lee CI; Lee HG; Kim JW; Yeom YI; Kim DG; Yoon SK; Kim JW; Park PJ; Song EY
Amino Acids; 2011 Mar; 40(3):1003-13. PubMed ID: 20821239
[TBL] [Abstract][Full Text] [Related]
11. SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition.
Xu J; Li X; Yang H; Chang R; Kong C; Yang L
Cancer; 2013 Jun; 119(12):2247-57. PubMed ID: 23564492
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
13. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
14. Role of a novel splice variant of mitotic arrest deficient 1 (MAD1), MAD1beta, in mitotic checkpoint control in liver cancer.
Sze KM; Ching YP; Jin DY; Ng IO
Cancer Res; 2008 Nov; 68(22):9194-201. PubMed ID: 19010891
[TBL] [Abstract][Full Text] [Related]
15. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition.
Chung KY; Cheng IK; Ching AK; Chu JH; Lai PB; Wong N
Hepatology; 2011 Jul; 54(1):307-18. PubMed ID: 21520196
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma.
Li X; Li Y; Xu A; Zhou D; Zhang B; Qi S; Chen Z; Wang X; Ou X; Cao B; Qu C; Huang J
Oncoimmunology; 2021; 10(1):1992104. PubMed ID: 34676150
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ
Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617
[TBL] [Abstract][Full Text] [Related]
19. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
Chan TH; Chen L; Liu M; Hu L; Zheng BJ; Poon VK; Huang P; Yuan YF; Huang JD; Yang J; Tsao GS; Guan XY
Hepatology; 2012 Feb; 55(2):491-505. PubMed ID: 21953552
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological significance of Cdk10 in hepatocellular carcinoma.
Zhong XY; Xu XX; Yu JH; Jiang GX; Yu Y; Tai S; Wang ZD; Cui YF
Gene; 2012 Apr; 498(1):68-74. PubMed ID: 22326270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
